Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001649553-25-000060·Aptevo Therapeutics Inc.
Schedule 13G ownership disclosure
Aptevo Therapeutics Inc (US) OLD
Common Stock, $0.001 par value per share · CUSIP: 03835L405
Event date: 2025-04-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- CVI Investments, Inc.
Shares: 200,000 · Class: 6.2%
- Heights Capital Management, Inc.
Shares: 200,000 · Class: 6.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001649553-25-000060
- Form type
- SCHEDULE 13G
- Filer
- Aptevo Therapeutics Inc.
- CIK
- CIK 1671584
- Filed
- Apr 10, 2025
- Reporting period
- Apr 03, 2025
- Description
- Schedule 13G beneficial ownership